Linagliptin inhibits lipopolysaccharide-induced inflammation in human U937 monocytes

• Main Authors: Shiho Yamadera (Author), Yuya Nakamura (Author), Masahiro Inagaki (Author), Sachiyo Kenmotsu (Author), Tetsuhito Nohara (Author), Naoki Sato (Author), Tatsunori Oguchi (Author), Mayumi Tsuji (Author), Isao Ohsawa (Author), Hiromichi Gotoh (Author), Yoshikazu Goto (Author), Akihiko Yura (Author), Yuji Kiuchi (Author), Shinichi Iwai (Author)
• Format: Book
• Published: BMC, 2018-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Atherosclerosis and inflammation are more common in patients with diabetes than in patients without diabetes, and atherosclerosis progression contributes to inflammation. Therefore, anti-inflammatory therapy is important for the prognosis of patients with diabetes. Linagliptin is...